[go: up one dir, main page]

Aramoto et al., 1992 - Google Patents

A case of contact dermatitis due to methylprednisolone

Aramoto et al., 1992

Document ID
15387304484016403237
Author
Aramoto Y
Uemura T
Akiyoshi E
Murata Y
Kawashima M
Publication year
Publication venue
The Journal of Dermatology

External Links

Snippet

A 46‐year‐old woman developed contact dermatitis on her face after application of an ointment containing 0.1% methylprednisolone and 0.35% fradiomycin. Her patch test result was positive with methylprednisolone, but not with fradiomycin. No cross‐reactions were …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00—Cosmetic or similar toilet preparations
    • A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
    • A61K8/30—Cosmetic or similar toilet preparations characterised by the composition containing organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems

Similar Documents

Publication Publication Date Title
JP2945993B2 (en) External preparation
CHRISTY et al. Comparative effects of prednisone and of cortisone in suppressing the response of the adrenal cortex to exogenous adrenocorticotropin
US3980778A (en) Anti-inflammatory steroid
Allenby et al. Effect on adrenal function of topically applied clobetasol propionate (Dermovate).
Meding et al. Contact allergy to budesonide in a nasal spray.
NELSON et al. Potentiation of the biologic effect of administered cortisol by estrogen treatment
Tegner Contact allergy to corticosteroids
Lauerma Contact hypersensitivity to glucocorticosteroids
Wilson et al. Plasma corticosteroid levels in out‐patients treated with topical steroids
KR910011279A (en) A method for reducing or preventing side effects caused by steroid therapy and a composition therefor
Coskey Adverse effects of corticosteroids: I. Topical and intralesional
Aramoto et al. A case of contact dermatitis due to methylprednisolone
TAYLOR et al. Pituitary-adrenal function following topical triamcinolone acetonide and occlusion
Sneddon Clinical use of topical corticosteroids
Hillström et al. Comparison of betamethasone dipropionate lotion with salicylic acid (Diprosalic®) and clobetasol propionate lotion (Dermovate®) in the treatment of psoriasis of the scalp
Iglesias-Cadarso et al. Allergic contact dermatomucositis to budesonide
March et al. Adrenal function after topical steroid therapy
Lee Topical steroids.
Aso The effects of potent topical corticosteroids on adrenocortical function
Lassus Alclometasone dipropionate cream 0.05% versus clobetasone butyrate cream 0.05% A controlled clinical comparison in the treatment of atopic dermatitis in children
Ortonne Safety aspects of topical methylprednisolone aceponate (MPA) treatment
US4131652A (en) Medicinal skin cream for psoriasis and method
US3178345A (en) Topical steroid composition
Carr et al. Adrenocortical suppression with small doses of topical corticosteroids.
Bongiovanni et al. Differences in metabolism of Reichstein's substance S in normal adults and children